SEC Form 4 · accession 0001376339-18-000017
MIMEDX GROUP, INC. · MDXG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael J. Senken
Officer — Chief Financial Officer
Period of report
Feb 22, 2018
Accepted (ET)
Feb 26, 2018 · 4:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001376339
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 22, 2018 | F | 4,390 | $8.88 | D | 238,594 | D | |
| Common Stock | Feb 22, 2018 | F | 8,075 | $8.88 | D | 230,519 | D | |
| Common Stock | Feb 22, 2018 | A | 46,200 | $8.88 | A | 276,719 | D | |
| Common Stock | Feb 25, 2018 | F | 3,189 | $7.83 | D | 273,530 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares withheld to pay applicable withholding taxes upon vesting of 1/3 of Restricted Stock Award granted in a prior year.
- F2Represents Restricted Stock Award granted on February 22, 2018, in accordance with the Company's annual grant process, under which restricted shares shall vest pursuant to the Company's standard vesting schedule of 1/3 of shares vesting on each of the first, second and third anniversary dates of the grant date of the Restricted Stock Award.